EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Dyslipidemia With Reproductive Hormone Profiles and Menstrual Regularity in Patients With Polycystic Ovary Syndrome

Xinyi Shi, Yanyu Zhong, Qing Zhao, Xuanping Lu, Yanping Pan

British Journal of Hospital Medicine · 19.10.2026 · 87 (10)

DOI: 10.31083/bjhm52491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 19.10.2026. Verfasst von Xinyi Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Reproductive Medicine Centre, The First Affiliated Hospital of Soochow University, 215006 Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Dyslipidemias. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Background: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder among women of reproductive age, often accompanied by dyslipidemia. However, the direct association between dyslipidemia and reproductive hormone profiles and menstrual regularity remains unclear. This study aimed to retrospectively analyze the association of dyslipidemia with reproductive hormone levels and menstrual regularity in patients with PCOS.

Methods

This was a single-center retrospective cross-sectional study that included 324 patients with PCOS who visited The First Affiliated Hospital of Soochow University between June 2021 and June 2025. Based on the inclusion and exclusion criteria, 236 patients were ultimately included. Patients were divided into a dyslipidemia group (n = 121) and a eulipidemia group (n = 115) based on their lipid profiles. General demographic data, lipid levels, reproductive hormone levels, and menstrual history were collected. Multiple linear regression was used to examine the independent associations between lipid levels and reproductive hormone levels, whereas multivariate logistic regression was used to examine the relationship between lipid levels and menstrual regularity.

Results

Patients in the dyslipidemia group had significantly higher levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and total testosterone (TT) than those in the eulipidemia group (all p < 0.001), significantly lower estradiol (E2) levels (p < 0.001), and a significantly higher incidence of menstrual irregularities (90.08% vs. 43.48%, p < 0.001). Multiple linear regression analysis showed that, after adjusting for age, body mass index (BMI), and homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C) were independently positively associated with TT, FSH, and LH, whereas high-density lipoprotein cholesterol (HDL-C) was independently and negatively associated with TT and FSH (all p < 0.001). HDL-C was positively associated with E2, whereas LDL-C was negatively associated with E2; however, these associations did not remain significant after correction for multiple comparisons. TG and LDL-C were independently and negatively associated with sex hormone-binding globulin (SHBG) (all p < 0.01). Multivariate logistic regression analysis showed that TG (OR = 2.126, 95% CI: 1.088–4.156, p = 0.027) and HDL-C (OR = 0.153, 95% CI: 0.052–0.448, p < 0.001) were independently associated with menstrual irregularity.

Conclusion

In patients with PCOS, dyslipidemia is closely associated with reproductive hormone imbalances and menstrual irregularity. TG and HDL-C levels were independently associated with menstrual regularity. Dyslipidemia is not only a metabolic abnormality but may also contribute to the development of the endocrine phenotype of PCOS. Clinical management should consider the potential value of lipid-targeted interventions in improving reproductive and menstrual outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeDyslipidemiasHumansFemaleRetrospective StudiesCross-Sectional StudiesAdultLuteinizing HormoneFollicle Stimulating HormoneTestosteroneEstradiolYoung AdultLipidsSex Hormone-Binding Globulin

Stichwörter der Autor:innen

dyslipidemiamenstrual irregularitymenstruation disturbancespolycystic ovary syndromereproductive hormones

Substanzen

Luteinizing HormoneFollicle Stimulating HormoneTestosteroneEstradiolLipidsSex Hormone-Binding Globulin

Autor:innen und Institutionen

  • The Reproductive Medicine Centre, The First Affiliated Hospital of Soochow University, 215006 Suzhou, Jiangsu, China.

Zitieren

APA

Shi, X., Zhong, Y., Zhao, Q., Lu, X., & Pan, Y. (2026). Association of Dyslipidemia With Reproductive Hormone Profiles and Menstrual Regularity in Patients With Polycystic Ovary Syndrome. British Journal of Hospital Medicine, 87(10). https://doi.org/10.31083/bjhm52491

Vancouver

Shi X, Zhong Y, Zhao Q, Lu X, Pan Y. Association of Dyslipidemia With Reproductive Hormone Profiles and Menstrual Regularity in Patients With Polycystic Ovary Syndrome. British Journal of Hospital Medicine. 2026;87(10). doi:10.31083/bjhm52491

BibTeX
@article{Shi2026,
  author = {Shi, Xinyi and Zhong, Yanyu and Zhao, Qing and Lu, Xuanping and Pan, Yanping},
  title = {Association of Dyslipidemia With Reproductive Hormone Profiles and Menstrual Regularity in Patients With Polycystic Ovary Syndrome},
  journal = {British Journal of Hospital Medicine},
  year = {2026},
  volume = {87},
  number = {10},
  doi = {10.31083/bjhm52491}
}
Kostenlos starten →